Medspan Biogenics And Mediquips Private Limited
Founded in 2022 and headquartered in West Bengal, India.
2022 | 24 Parganas, West Bengal (India) | Active
Medspan Biogenics And Mediquips Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Medspan Biogenics And Mediquips
Medspan Biogenics And Mediquips Private Limited (MBAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2022 (Two years and six months 28 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shukla Das and Kalpana De serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290WB2022PTC256090
- Company No.
256090
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Chemicals
Who are the key members and board of directors at Medspan Biogenics And Mediquips?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shukla Das  | Director | 01-Aug-2022 | Current |
| Kalpana De | Director | 01-Aug-2022 | Current |
Financial Performance of Medspan Biogenics And Mediquips.
Enhance accessibility to Medspan Biogenics And Mediquips's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medspan Biogenics And Mediquips?
Unlock access to Medspan Biogenics And Mediquips's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medspan Biogenics And Mediquips?
Medspan Biogenics And Mediquips has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medspan Biogenics And Mediquips, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medspan Biogenics And Mediquips's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.